Close

Ms Sarah Harman

Research Programme Manager

United Kingdom

Affiliations

Department of Infectious Disease Epidemiology and International Health
Faculty of Epidemiology and Population Health

Selected Publications

Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.
HARMAN, S; Herrera, C; Armanasco, N; Nuttall, J; Shattock, RJ;
2012
Antimicrobial agents and chemotherapy
Design, expression, and characterization of a multivalent, combination HIV microbicide.
Sexton, A; HARMAN, S; Shattock, RJ; Ma, JK-C;
2009
FASEB journal
Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.
Fletcher, P; HARMAN, S; Azijn, H; Armanasco, N; Manlow, P; Perumal, D; De Bethune, M-P; Nuttall, J; Romano, J; Shattock, R;
2008
Antimicrobial agents and chemotherapy
Preclinical evaluation of lime juice as a topical microbicide candidate.
Fletcher, PS; HARMAN, SJ; Boothe, AR; Doncel, GF; Shattock, RJ;
2008
Retrovirology
Transgenic plant production of Cyanovirin-N, an HIV microbicide.
Sexton, A; Drake, PM; Mahmood, N; HARMAN, SJ; Shattock, RJ; Ma, JK-C;
2005
FASEB journal
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
Herrera, C; HARMAN, S; Aldon, Y; Rogers, P; Armanasco, N; Ziprin, P; Stieh, D; Nuttall, J; Shattock, RJ;
2021
AIDS (London, England)
See more information